Latest Angiodynamics (ANGO) Headlines Wednesday's Top

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Angiodynamics (ANGO) Headlines

Wednesday's Top Upgrades (and Downgrades)
Rich Smith, The Motley Fool - Motley Fool - Wed Mar 12, 11:00AM CDT
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature downgrades for clothiers Urban Outfitters and American Eagle Outfitters . But...

Upgrade Alert for Angiodynamics (ANGO)
Comtex SmarTrend(R) - Wed Mar 12, 7:05AM CDT
Angiodynamics (NASDAQ:ANGO) was upgraded from Market Perform to Outperform at Raymond James today. The stock closed yesterday at $15.85 on volume of 175,000 shares, above average daily volume of 146,000. AngioDynamics, Inc. designs, develops, manufactures, and markets therapeutic and diagnostic devices. The Company's products enable interventional physicians to treat peripheral vascular disease and other non-coronary diseases. AngioDynamic's product lines consist of angiographic catheters, hemodialysis catheters, image guided vascular access products, and thrombolytic products.

AngioDynamics Receives Expanded FDA Clearance for AngioVac
GlobeNewswire - Tue Mar 11, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) cleared an expanded indication for its AngioVac cannula for venous drainage during extracorporeal bypass for up to six hours to include removal of fresh, soft thrombi or emboli.

AngioDynamics Gets 3rd FDA Approval for BioFlo - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 4:30PM CDT
The commercial launch of the catheter, which is expected in the fourth quarter of fiscal year 2014, is likely to boost ANGO's 15% share in the $100 million chronic dialysis catheter market.

AngioDynamics Receives FDA Clearance for DuraMax Dialysis Catheter With BioFlo Technology to Reduce Catheter-Related Thrombus
GlobeNewswire - Fri Mar 07, 5:30AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration granted 510(k) clearance for its BioFlo DuraMax chronic hemodialysis catheter.

AngioDynamics Updates U.S. Tip Location Strategy
GlobeNewswire - Fri Mar 07, 2:59AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) rejected its distribution partner, Medcomp Inc.'s, 510(k) application for the Celerity tip location system.

Coverage on Covance Initiated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:20PM CST
On Mar 06, 2014, we initiated coverage on Covance.

Cyberonics Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 2:10PM CST
On Feb 26, 2014, Zacks Investment Research upgraded Cyberonics Inc. to a Zacks Rank #2 (Buy).

AngioDynamics to Present at the Barclays Global Healthcare Conference
GlobeNewswire - Mon Mar 03, 6:00AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to address the Barclays Global Healthcare Conference on Tuesday, March 11, 2014, at 4:15 p.m. ET. The conference will be held at the Loews Hotel in Miami, Fla.

BioScrip Down on Q4 Loss, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 10:30AM CST
BioScrip recently declared its fourth-quarter 2013 results.

Fresenius Medical Care Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 9:20AM CST
For full-year 2013, FMS reported a 6.5% fall in net earnings to $1.1 billion and a 6% drop in net earnings per share to $1.83.

Q4 Earnings Beat at AmSurg, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:10AM CST
AmSurg Corp.'s fourth-quarter 2013 EPS from continuing operations climbed 22% year over year to 60 cents.

Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.

Wider Q4 Loss, Poor Outlook at Volcano Corp. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:00AM CST
Volcano Corporation reported adjusted net loss of 29 cents per share in the fourth quarter of 2013, wider than the Zacks Consensus Estimate loss of 24 cents per share.

Balanced View on PetMed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 5:00PM CST
On Feb 19, 2014, we issued an updated research report on PetMed Express.

Updated Research Report on Cepheid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 2:00PM CST
Recently, we issued an updated research report on Cepheid.

Why Cynosure (CYNO) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:54AM CST
Cynosure has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy

Pacific Biosciences (PACB) Jumps: Stock Moves 8.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:46AM CST
Pacific Biosciences was a big mover last session, with shares rising over 8%.

Masimo Q4 Earnings Meet Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 2:43PM CST
For full year 2013, adjusted earnings per share rose 11.5% to $1.16, in line with the Zacks Consensus Estimate.

NASSCORP Holds Awareness Forum
by Namoteekollie From Bong County - All Africa Global Media - Thu Feb 13, 6:01AM CST
An interactive forum between employers and employees organized by the National Social Security and Welfare Corporation (NASSCORP) has ended in Gbarnga, Bong County with the objective of explaining the day-to-day operations of the corporation to employees and employers for better understanding of the entity.

AngioDynamics Inc. (ANGO) Stock Research Links

ANGO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 7

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 6

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 8

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading

Top 5 Most Recently Viewed Articles

Rosen Law Firm Supports DexCom, Inc. Investors Facing Losses

Updated Category News Views 59

Understanding Your Rights as a DexCom, Inc. Investor The recent developments surrounding DexCom, Inc. (NASDAQ: DXCM) are raising important questions among investors. Rosen Law Firm, a prominent global investor rights law firm, is actively reaching out to stockholders affected by substantial losses during a particular period. The firm has announced that a class action...

Continue Reading
CVS Health's New Report Highlights Community Pharmacy Evolution

Updated Category News Views 211

CVS Health Highlights Community Pharmacy Transformation CVS Health (NYSE: CVS) recently released a vital report shedding light on the evolution of community pharmacies. This report signifies the company’s commitment to enhancing pharmacy services and addressing the needs of the community. Insights drawn from a survey conducted by CVS Health and Morning Consult indicate...

Continue Reading
Estée Lauder's Bold Strategy for Profits and Workforce Cuts

Updated Category News Views 270

Estée Lauder's Recent Financial Performance Estée Lauder Companies Inc. (NYSE: EL) recently surprised the market with better-than-expected financial results for the first quarter, which contributed to a notable rise in premarket trading. The company's performance reaffirmed positive sales projections for the coming years, revealing a strong start to their fiscal...

Continue Reading
Moderna's Stock Decline: Navigating Challenges and Opportunities

Updated Category News Views 59

Moderna Faces Market Pressures as Stock Hits Low In a challenging market environment, Moderna Inc. (NASDAQ: MRNA) stock has tragically reached a 52-week low, dipping to $57.71. The biotechnology company is well-known for its innovative mRNA-based vaccines and has found itself grappling with a tumultuous year. Over the past twelve months, Moderna's shares have plummeted by...

Continue Reading
Wolters Kluwer's Tomorrow: A Leadership Transition Ahead

Updated Category News Views 298

Wolters Kluwer's Exciting Leadership Shift Wolters Kluwer, known for its innovative approach in the fields of healthcare, law, and regulatory solutions, has recently announced a significant leadership change set to unfold in early 2026. After a remarkable journey and a profound impact on the company, Nancy McKinstry has shared her decision to retire from her esteemed role...

Continue Reading